Clinical Proteomics
News on proteomics applications for clinical use in genetics, genomics, and molecular diagnostics.
In a recent study, the 48-protein panel improved the diagnostic performance of existing Alzheimer's markers and helped predict progression of the disease.
Octave Bioscience to Conduct Real-World Multiple Sclerosis Study Using Management Platform
The 150-patient, Biogen-sponsored study will use Octave's Precision Care Solution platform to better understand how MS progresses.
Using a protein biomarker signature, the company is advancing a CHK1/2 inhibitor that Eli Lilly out-licensed after seeing limited responses in genomic subgroups.
Theralink to Become Subsidiary of IMAC via Stock-for-Stock Reverse Merger
Theralink will become a wholly owned subsidiary of IMAC focused on proteomic testing for guiding cancer therapy and drug development.
SkylineDx, NeraCare Partnering on Proteomic Test for Melanoma
The companies inked a codevelopment and licensing agreement for NeraCare's Immunoprint test for identifying high-risk early-stage melanoma patients.